BMY
Price
$58.91
Change
-$0.18 (-0.30%)
Updated
Sep 22, 6:59 PM EST
32 days until earnings call
LLY
Price
$550.11
Change
-$0.02 (-0.00%)
Updated
Sep 22, 6:59 PM EST
39 days until earnings call

Compare predictions BMY vs LLY

Header iconBMY vs LLY Comparison
Open Charts BMY vs LLYBanner chart's image
Bristol-Myers Squibb
Price$58.91
Change-$0.18 (-0.30%)
Volume$2.94M
CapitalizationN/A
Eli Lilly & Co
Price$550.11
Change-$0.02 (-0.00%)
Volume$702.39K
CapitalizationN/A
View a ticker or compare two or three
BMY vs LLY Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BMY vs. LLY commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Hold and LLY is a StrongBuy.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (BMY: $58.90 vs. LLY: $550.54)
Brand notoriety: BMY and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 73% vs. LLY: 81%
Market capitalization -- BMY: $123.05B vs. LLY: $522.62B
BMY [@Pharmaceuticals: Major] is valued at $123.05B. LLY’s [@Pharmaceuticals: Major] market capitalization is $522.62B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $522.62B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $80.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green whileLLY’s FA Score has 3 green FA rating(s).

  • BMY’s FA Score: 1 green, 4 red.
  • LLY’s FA Score: 3 green, 2 red.
According to our system of comparison, LLY is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish while LLY’s TA Score has 3 bullish TA indicator(s).

  • BMY’s TA Score: 4 bullish, 4 bearish.
  • LLY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BMY is a better buy in the short-term than LLY.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -0.22% price change this week, while LLY (@Pharmaceuticals: Major) price change was -4.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.88%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was -0.33%.

Reported Earning Dates

BMY is expected to report earnings on Oct 26, 2023.

LLY is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-1.88% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for BMY with price predictions.
OPEN
A.I.dvisor published
a Summary for LLY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LLY($523B) has a higher market cap than BMY($123B). LLY has higher P/E ratio than BMY: LLY (76.92) vs BMY (15.67). LLY YTD gains are higher at: 51.691 vs. BMY (-16.072). BMY has higher annual earnings (EBITDA): 19.8B vs. LLY (9.14B). BMY has more cash in the bank: 8.73B vs. LLY (2.83B). LLY has less debt than BMY: LLY (18.8B) vs BMY (39.2B). BMY has higher revenues than LLY: BMY (45.2B) vs LLY (29.5B).
BMYLLYBMY / LLY
Capitalization123B523B24%
EBITDA19.8B9.14B217%
Gain YTD-16.07251.691-31%
P/E Ratio15.6776.9220%
Revenue45.2B29.5B153%
Total Cash8.73B2.83B309%
Total Debt39.2B18.8B209%
FUNDAMENTALS RATINGS
BMY vs LLY: Fundamental Ratings
BMY
LLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
591
SMR RATING
1..100
3917
PRICE GROWTH RATING
1..100
6236
P/E GROWTH RATING
1..100
8420
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (3) in the Pharmaceuticals Major industry is somewhat better than the same rating for LLY (65). This means that BMY’s stock grew somewhat faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (59). This means that LLY’s stock grew somewhat faster than BMY’s over the last 12 months.

LLY's SMR Rating (17) in the Pharmaceuticals Major industry is in the same range as BMY (39). This means that LLY’s stock grew similarly to BMY’s over the last 12 months.

LLY's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as BMY (62). This means that LLY’s stock grew similarly to BMY’s over the last 12 months.

LLY's P/E Growth Rating (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (84). This means that LLY’s stock grew somewhat faster than BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYLLY
RSI
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
50%
Advances
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 13 days ago
67%
Declines
ODDS (%)
Bearish Trend 7 days ago
54%
Bearish Trend 4 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
47%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRND5.700.14
+2.52%
Grindr
GLG0.15N/A
+1.00%
TD Holdings
KMB123.97-1.30
-1.04%
Kimberly-Clark Corp
LYFT9.94-0.39
-3.78%
Lyft
BARK1.25-0.05
-3.85%
BARK

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with PFE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
-0.30%
PFE - BMY
49%
Loosely correlated
-0.49%
MRK - BMY
48%
Loosely correlated
-0.37%
GILD - BMY
45%
Loosely correlated
-0.35%
JNJ - BMY
45%
Loosely correlated
-0.72%
AMGN - BMY
40%
Loosely correlated
-0.63%
More

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with BIIB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.07%
BIIB - LLY
50%
Loosely correlated
-0.48%
MRK - LLY
44%
Loosely correlated
-0.37%
NVS - LLY
42%
Loosely correlated
-0.93%
AMGN - LLY
40%
Loosely correlated
-0.63%
GILD - LLY
39%
Loosely correlated
-0.35%
More